Patent Foramen Ovale in Cryptogenic Stroke: Current Understanding and Management Options

Archives of Internal Medicine

Volumn 164, Issue 9, 2004, Pages 950-956

  Wu, Lambert A ^a   Malouf, Joseph F ^a   Dearani, Joseph A ^a   Hagler, Donald J ^a   Reeder, Guy S ^a   Petty, George W ^a   Khandheria, Bijoy K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; WARFARIN;

ATHEROSCLEROSIS; CARDIOVASCULAR MALFORMATION; CEREBROVASCULAR DISEASE; CRYPTOGENIC STROKE; DEVICE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HEART ATRIUM SEPTUM DEFECT; HUMAN; IMPLANTATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ADULT; ALGORITHMS; ANTICOAGULANTS; BALLOON DILATATION; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIDDLE AGED; PROGNOSIS; RECURRENCE; VALSALVA MANEUVER; WARFARIN;

EID: 2342516160     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.9.950     Document Type: Review

References (64)

1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17-20.
2. Patten BM. The closure of the foramen ovale. Am J Anat. 1931;48:19-44.
3. Sweeney LJ, Rosenquist GC. The normal anatomy of the atrial septum in the human heart. Am Heart J. 1979;98:194-199.
4. Schroeckenstein RF, Wasenda GJ, Edwards JE. Valvular competent patent foramen ovale in adults. Minn Med. 1972;55:11-13.
5. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study: Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc. 1999;74:862-869.
6. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996;334:1216-1221.
7. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331:1474-1479.
8. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA. Proximal aortic atheroma: an independent risk factor for cerebral ischemia. Stroke. 1995;26:218-224.
9. Meissner I, Wiebers DO, Whisnant JP, O'Fallon WM. The natural history of asymptomatic carotid artery occlusive lesions. JAMA. 1987;258:2704-2707.
10. Wiebers DO, Whisnant JP, Sandok BA, O'Fallon WM. Prospective comparison of a cohort with asymptomatic carotid bruit and a population-based cohort without carotid bruit. Stroke. 1990; 21:984-988.
11. Levy DE. Transient CNS deficits: a common, benign syndrome in young adults. Neurology. 1988; 38:831-836.
12. Bogousslavsky J, Regli F. Ischemic stroke in adults younger than 30 years of age: cause and prognosis. Arch Neurol. 1987;44:479-482.
13. Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Stroke. 1983;14:110-114.
14. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: a study using transesophageal echocardiography. Stroke. 1993;24:1865-1873.
15. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25:382-390.
16. Mohr JP. Cryptogenic stroke. N Engl J Med. 1988; 318:1197-1198.
17. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30:2513-2516.
18. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55:1172-1179.
19. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625-2631.
20. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106:1121-1126.
21. Lynch JJ, Schuchard GH, Gross CM, Wann LS. Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol. 1984;53:1478-1480.
22. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986;112:141-145.
23. Lechat P, Mas JL, Lascauit G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-1152.
24. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet. 1988;2:11-12.
25. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke. 1993; 24:31-34.
26. Johnson BI. Paradoxical embolism. J Clin Pathol. 1951;4:316-332.
27. Petty GW, Khandheria BK, Chu CP, Sicks JD, Whisnant JP. Patent foramen ovale in patients with cerebral infarction: a transesophageal echocardiographic study. Arch Neurol. 1997;54:819-822.
28. Siostrzonek P, Lang W, Zangeneh M, et al. Significance of left-sided heart disease for the detection of patent foramen ovale by transesophageal contrast echocardiography. J Am Coll Cardiol. 1992;19:1192-1196.
29. Agmon Y, Khandheria BK, Meissner I, et al. Comparison of frequency of patent foramen ovale by transesophageal echocardiography in patients with cerebral ischemic events versus in subjects in the general population. Am J Cardiol. 2001;88:330-332.
30. Stollberger C, Schneider B, Abzieher F, Wollner T, Meinertz T, Slany J. Diagnosis of patent foramen ovale by transesophageal contrast echocardiography. Am J Cardiol. 1993;71:604-606.
31. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G, Lausanne Stroke with Paradoxical Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology. 1996;46:1301-1305.
32. Devuyst G, Bogoussalavsky J, Ruchat P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology. 1996;47:1162-1166.
33. Biller J, Johnson MR, Adams HP Jr, Kerber RE, Toffol GJ, Butler MJ. Echocardiographic evaluation of young adults with nonhemorrhagic cerebral infarction. Stroke. 1986;17:608-612.
34. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane transesophageal echocardiographic study. Stroke. 1994;25:582-586.
35. Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol. 1995;26:1030-1038.
36. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 1999;100 (suppl):11171-11175.
37. Stone DA, Godard J, Corretti MC, et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J. 1996;131:158-161.
38. De Castro S, Cartoni O, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407-2413.
39. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18:1223-1229.
40. Gallet B, Malergue MC, Adams C, et al. Atrial septal aneurysm-a potential cause of systemic embolism: an echocardiographic study. Br Heart J. 1985;53:292-297.
41. Belkin RN, Hurwitz BJ, Kisslo J. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke. 1987;18:856-862.
42. Hanna JP, Sun JP, Furlan AJ, Stewart WJ, Sila CA, Tan M. Patent foramen ovale and brain infarct: echocardiographic predictors, recurrence, and prevention. Stroke. 1994;25:782-786.
43. Silver MD, Dorsey JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med. 1978; 102:62-65.
44. Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol. 1985;6:1370-1382.
45. Mugge A, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91:2785-2792.
46. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.
47. Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991;17:66-72.
48. Lee RJ, Bartzokis T, Yeoh TK, Grogin HR, Choi D, Schnittger I. Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke. 1991;22:734-739.
49. Hamann GF, Schatzer-Klotz D, Frohlig G, et al. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology. 1998;50:1423-1428.
50. Blersch WK, Draganski BM, Holmer SR, et al. Transcranial duplex sonography in the detection of patent foramen ovale. Radiology. 2002;225:693-699.
51. Drgera MA, D'Malley PG, Taylor AJ. Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J. 2001;94:699-703.
52. Guffi M, Bogousslavsky J, Jeanrenaud X, Devuyst G, Sadeghi H. Surgical prophylaxis of recurrent stroke in patients with patent foramen ovale: a pilot study. J Thorac Cardiovasc Surg. 1996;112:260-263.
53. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 1997;28:2376-2381.
54. Nendaz MR, Sarasin FP, Junod AF, Bogousslavsky J. Preventing stroke recurrence in patients with patent foramen ovale: antithrombotic therapy, foramen closure, or therapeutic abstention? a decision analytic perspective. Am Heart J. 1998;135:532-541.
55. Rao PS, Berger F, Rey C, et al, for the International Buttoned Device Trial Group. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation Buttoned device: comparison with first, second and third generation devices. J Am Coll Cardiol. 2000;36:583-592.
56. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol. 2000;35:1311-1316.
57. Bridges ND, Hellenbrand W, Latson L, Fillano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86:1902-1908.
58. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation. 2000;101:893-898.
59. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter non-randomized trial. J Am Coll Cardiol. 2002;39:1836-1844.
60. Sievert H, Babic UU, Hausdorf G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDDS device (a multiinstitutional European trial). Am J Cardiol. 1998; 82:1405-1413.
61. Bungard TJ, Ackman ML, Ho G, Tsuyuki RT. Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital. Pharmacotherapy. 2000;20:1060-1065.
62. Malik AK, Taylor AJ. Can warfarin randomized trials be reproduced in "real life"? adherence to warfarin guidelines for intensity of anticoagulation in a university-based warfarin clinic. South Med J. 2000;93:58-61.
63. Seward JB, Hayes DL, Smith HC, et al. Platypnea-orthodeoxia: clinical profile, diagnostic workup, management: a report of seven cases. Mayo Clin Proc. 1984;59:221-231.
64. Anzola GP. Clinical impact of patent foramen ovale diagnosis with transcranial Doppler. Eur J Ultrasound. 2002;16:11-20.